anti chrebp (Proteintech)
Structured Review
Anti Chrebp, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chrebp/MLXIPL+Antibody/10__1016_slash_j__jff__2026__107485-73-0-4
Average 93 stars, based on 26 article reviews
Images
Related Articles
Control:Article Title: Postbiotics Prepared Using Lactobacillus reuteri Ameliorates Ethanol-Induced Liver Injury by Regulating the FXR/SHP/SREBP-1c Axis. Article Snippet: Scope: While probiotics-based therapies have exhibited potential in alleviating alcohol-associated liver disease (ALD), the specific role of postbiotics derived from Lactobacillus reuteri (L. reuteri) in ALD remains elusive.. This study aims to investigate the impact of postbiotics on ameliorating alcohol-induced hepatic steatosis and the underlying mechanisms.. Methods and results: Using network pharmacology, the study elucidates the targets and pathways impacted by postbiotics from L. reuteri, identifying the farnesoid X receptor (FXR) as a promising target for postbiotics against ALD, and lipid metabolism and alcoholism act as crucial pathways associated with postbiotics-targeting ALD. Article Title: Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP ‐1 Article Snippet: .. Antibodies for Lin28A, Lin28B, HK2, FASN, ACC1, ACLY, CPT1A, MCAD, SCAD, CD36, FABP1, FABP5, FATP2, FATP5, SREBP‐1, SCAP, Incubation:Article Title: Postbiotics Prepared Using Lactobacillus reuteri Ameliorates Ethanol-Induced Liver Injury by Regulating the FXR/SHP/SREBP-1c Axis. Article Snippet: Scope: While probiotics-based therapies have exhibited potential in alleviating alcohol-associated liver disease (ALD), the specific role of postbiotics derived from Lactobacillus reuteri (L. reuteri) in ALD remains elusive.. This study aims to investigate the impact of postbiotics on ameliorating alcohol-induced hepatic steatosis and the underlying mechanisms.. Methods and results: Using network pharmacology, the study elucidates the targets and pathways impacted by postbiotics from L. reuteri, identifying the farnesoid X receptor (FXR) as a promising target for postbiotics against ALD, and lipid metabolism and alcoholism act as crucial pathways associated with postbiotics-targeting ALD. other:Article Title: 6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in mice. Article Snippet: Excessive fructose consumption increases hepatic de novo lipogenesis, resulting in cellular stress, inflammation and liver injury.. Nogo-B is a resident protein of the endoplasmic reticulum that regulates its structure and function.. Hepatic Nogo-B is a key protein in glycolipid metabolism, and inhibition of Nogo-B has protective effects against metabolic syndrome, thus small molecules that inhibit Nogo-B have therapeutic benefits for glycolipid metabolism disorders. |

